Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about

< Previous 1 2 3 4 5 6 7 Next >
UPDATE 2-Novartis top lawyer exits in wake of Trump attorney deal
* CEO highlights pipeline strength, scope for bolt-on M&A (Adds CEO comments on strategy) 
Tags companyNews
From Reuters: Company News
Notable ETF Inflow Detected - XBI, AVXS, SRPT, ONCE
Symbols mentioned in this story: XBI, AVXS, SRPT, ONCE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform
Biotechs soared Friday immediately after Trump’s much-anticipated new drug plan speech which was going to address high drug prices and potentially bring more government intervention. 
Tags ETFs Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Short Interest Declines 18.3% For AVXS
The most recent short interest data has been released for the 04/13/2018 settlement date, which shows a 681,577 share decrease in total short interest for AveXis Inc (AVXS), to 3,040,624, a decrease of... 
Tags Stocks
From Market News Video
Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling the Peaks (Stocks hitting 52-week ... 
Tags ADMS AGIO Top Stories
From Benzinga
Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags COCP HOLX TTNP
From Benzinga
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags Benzinga CDNA NBIX
From Benzinga
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Here's what you need to know about the M&A mania spreading through big pharma. 
Tags CELG NVS SHPG
From Motley Fool
XBI, AVXS, ONCE, SRPT: Large Inflows Detected at ETF
Symbols mentioned in this story: XBI, AVXS, ONCE, SRPT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
BRIEF-AveXis Announces First Patient Dosed In Phase 3 Trial Of AVXS-101 In Pre-Symptomatic SMA Types 1, 2 And 3
* AVEXIS ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 TRIAL OF AVXS-101 IN PRE-SYMPTOMATIC SMA TYPES 1, 2 AND 3 Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
Biotech And Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
BRIEF-Adage Capital Partners GP LLC Reports 6.04 Percent Stake In Avexis
* ADAGE CAPITAL PARTNERS GP LLC REPORTS 6.04 PERCENT STAKE IN AVEXIS INC AS OF APRIL 11 - SEC FILING 
Tags companyNews
From Reuters: Company News
A tale of two deals—ahead of earnings, Biogen move perplexes
Biogen just announced a $1 billion deal, but it may not be enough to make investors happy. 
Tags Health/Care Medical Products KR:102780
From MarketWatch
UPDATE 4-Novartis CEO feels heat on U.S. generics, Cosentyx drop
* Cosentyx sales drop since Q4 worries analysts (Adds comments from CEO, updates shares) 
Tags companyNews
From Reuters: Company News
UPDATE 3-New Novartis CEO feels heat on U.S. generics business
* Cosentyx sales miss average analyst forecast (Recasts story to focus on Cosentyx, Sandoz; adds share performance) 
Tags companyNews
From Reuters: Company News
UPDATE 2-Novartis confirms 2018 targets as Alcon recovery gains steam
* Cosentyx sales miss analyst forecast (Adds analyst forecast) 
Tags companyNews
From Reuters: Company News
UPDATE 1-Novartis confirms 2018 targets as Alcon recovery gains steam
* Cosentyx sales miss analysts' forecast (Adds comment from CEO, details about drugs.) 
Tags companyNews
From Reuters: Company News
Noteworthy ETF Outflows: XBI, AVXS, ONCE, ICPT
Symbols mentioned in this story: XBI, AVXS, ONCE, ICPT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Benzinga's Top Upgrades, Downgrades For April 18, 2018
Top Upgrades Morgan Stanley upgraded eBay Inc. (NASDAQ: EBAY) from Underweight to Overweight. eBay shares rose 6.25 percent ... 
Tags TEAM AKS Upgrades
From Benzinga
AveXis Larger Than S&P 500 Component AES
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component AveXis Inc (AVXS) was identified as having a larger market cap than the smaller end of the S&P 500, for... 
Tags Stocks
From Market News Video
Notable Tuesday Option Activity: AVXS, PIR, I
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in AveXis Inc (AVXS), where a total of 12,746 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
3 Biotech Stocks That Soared This Week: Are They Buys?
Tags AVXS NVS ABEO
From Motley Fool
Benzinga's Top Upgrades, Downgrades For April 13, 2018
Top Upgrades BMO Capital upgraded Eli Lilly and Company (NYSE: LLY) from Underperform to Market Perform. Eli Lilly shares ... 
Tags ECYT ZAYO ESV
From Benzinga
These 3 Biotech Stocks Are Up More Than 500% Over the Last 3 Years
Tags CELG AVXS NKTR
From Motley Fool
UPDATE 2-GSK slims portfolio with sale of rare disease gene therapy drugs
* Deal includes "bubble baby" gene therapy drug Strimvelis (Updates with Orchard CEO interview, more on gene therapy) 
Tags companyNews
From Reuters: Company News
Harry Boxer’s five biotech stocks to watch
In focus: uniQure, Regenxbio, Tandem Diabetes Care, Vericel and Xencor. 
Tags VCEL XNCR RGNX
From MarketWatch
UPDATE 2-Biotech M&A rolls on as Alexion snaps up Wilson for $855 mln
* U.S. company says first step in rebuilding pipeline (Adds latest shares, analyst reaction) 
Tags companyNews
From Reuters: Company News
Benzinga's Top Upgrades, Downgrades For April 11, 2018
Top Upgrades Mizuho upgraded Synaptics Incorporated (NASDAQ: SYNA) from Neutral to Buy. Synaptics shares rose 4.59 percent to ... 
Tags JPM AMG MKL
From Benzinga
The Market In 5 Minutes: Trump, Syria, Zuckerberg, Icahn And More
IN THE NEWS Stocks came under pressure on Wednesday amid a slew of catalysts, as investors prepared for the latest U.S. inflation ... 
Tags Market in 5 minutes FB AVXS
From Benzinga
UPDATE 1-Biotech M&A rolls on as Alexion snaps up Wilson for $855 mln
* U.S. company says first step in rebuilding pipeline (Adds details on Wilson medicine, wider industry context) 
Tags companyNews
From Reuters: Company News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.